First-in-Class Lupus Drug Aces Phase III Test

(MedPage Today) -- BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory systemic lupus erythematosus (SLE) get symptoms under control, according to phase III trial data...